No blend trials identified yet
No published clinical study of this three peptide blend was identified on PubMed. Evidence comes from each component studied separately. Reported in the cited paper.
SourceBack to search
HealingAnti-AgingBlends
GLOW (GHK-Cu + BPC-157 + TB-500)
GLOW is a three peptide blend combining GHK-Cu, BPC-157 and TB-500. It is used in regenerative, cosmetic and recovery research contexts, pairing collagen signalling with angiogenesis and actin regulation. The blend itself has no published clinical trial.
- Lowest cost / mg
- $0.64/mg
- at Reta One Labs
- Vendors listed
- 68
- In stock
- 71 of 74
- listings
- COA reports
- 54
Vendor listings
Compare GLOW (GHK-Cu + BPC-157 + TB-500) prices.
Show prices as
73 listings · GLOW (GHK-Cu + BPC-157 + TB-500)
- Reta One LabsLowest $/mg
In stock70mgseen 6d ago
In stock70mgseen 6d ago
In stock70mgseen 4d ago
In stock70mgseen 6d ago
In stock70mgseen 6d ago
In stock70mgseen 7d ago
In stock70mgseen 3d ago
In stock70mgseen 4d ago
In stock70mgseen 7d ago
In stock70mgseen 4d ago
In stock70mgseen 4d ago
In stock70mgseen 4d ago
In stock70mgseen 3d ago
In stock70mgseen 3d ago
In stock70mgseen 3d ago
In stock70mgseen 4d ago
In stock70mgseen 3d ago
In stock70mgseen 4d ago
In stock70mgseen 6d ago
In stock50mgseen 5d ago
Overview
What is GLOW (GHK-Cu + BPC-157 + TB-500)?
GLOW is a three peptide blend combining GHK-Cu, BPC-157 and TB-500. It is used in regenerative, cosmetic and recovery research contexts, pairing collagen signalling with angiogenesis and actin regulation. The blend itself has no published clinical trial.
- Tissue Repair
- Skin Rejuvenation
- Recovery Support
- Collagen Support
What the research reports
Reported research benefits
Outcomes described across the published literature and ongoing study. Read each as research context rather than a promised personal result.
- 01
Three separate mechanism blend
Combines collagen and elastin signalling with angiogenic action and actin regulation, covering three separate repair pathways at once. Reported in research settings.
- 02
Skin and tissue repair focus
The GHK-Cu component adds a cosmetic dimension that the two repair peptides on their own do not provide. Reported in study settings and not promised as a personal result.
- 03
Recovery protocol convenience
Delivering three peptides in one vial reduces the number of separate reconstitutions and schedules to manage. Noted across the published research record.
- 04
Component level study evidence
Each peptide carries its own preclinical record, so the blend inherits the evidence of its parts rather than adding its own. Reported in research settings.
- 05
Popular recovery study blend
Widely used in regenerative and athletic recovery settings, which has produced a large body of user reported experience. Reported in research settings.
Dosage and protocol
Dosage and protocol reference
Blend protocols pair BPC-157 at 250 to 500 mcg and TB-500 at 2 to 5 mg weekly with GHK-Cu at 1 to 2 mg, across 4 to 8 weeks. Figures describe study protocols, not a personal regimen.
- Route
- Subcutaneous injection
- Example range
- Per component dose
- Frequency
- Daily to twice weekly
- Timing
- Dose on shortest component schedule. Refrigerate after reconstitution.
Clinical evidence
Clinical evidence and study base
The published record, labeled by strength so you can see what is settled and what is still emerging.
BPC-157 knee pain case data
A 2021 case series reported significant improvement in 87.5 percent of 17 knee pain patients given intra-articular BPC 157 across one year. Reported in the cited paper.
SourceGHK-Cu laser resurfacing RCT
A randomised trial of 13 patients found topical copper tripeptide produced no significant reduction in redness or wrinkles despite better satisfaction scores. Reported in the cited paper.
SourceInteractions
How it pairs with other peptides
- KPV peptide
- Added in KLOW style blends to target inflammatory signalling through a melanocortin derived route.
- Ipamorelin
- No known negative interaction. The growth hormone axis sits apart from all three repair mechanisms.
- Semaglutide
- No known negative interaction. Metabolic and tissue repair pathways do not overlap meaningfully.
- Copper supplements
- The GHK-Cu component already delivers copper, so additional sources add to total exposure.
Questions
Frequently asked questions.
What is GLOW (GHK-Cu + BPC-157 + TB-500)?
GLOW (GHK-Cu + BPC-157 + TB-500) is a peptide compound used in research settings. It is commonly studied for its role in healing, anti-aging, blends, and many researchers compare supplier quality, purity, and testing data before purchasing.
What are the research benefits of GLOW (GHK-Cu + BPC-157 + TB-500)?
GLOW (GHK-Cu + BPC-157 + TB-500) is often evaluated for its potential influence on signaling pathways, recovery support, and targeted research applications. Research interest varies by peptide, formulation, and study design, so buyers typically review purity, dose, and independent lab verification before choosing a source.
How does GLOW (GHK-Cu + BPC-157 + TB-500) work?
Like other research peptides, GLOW (GHK-Cu + BPC-157 + TB-500) is typically studied for how it interacts with specific biological pathways and receptor systems. In practice, the way it is formulated, dosed, and tested matters as much as the compound itself, which is why verified suppliers and transparent COAs are important.
Is GLOW (GHK-Cu + BPC-157 + TB-500) for research use only?
Yes, products like GLOW (GHK-Cu + BPC-157 + TB-500) are generally intended for research, laboratory, or educational use and are not marketed as approved human therapeutics. Always follow local laws, lab safety practices, and institutional requirements before handling or studying any peptide.
What should I look for before buying GLOW (GHK-Cu + BPC-157 + TB-500)?
Key checks include verified COA data, peptide form and concentration, supplier reputation, stock status, and cost per mg. Comparing pricing and testing records side-by-side helps reduce the risk of buying an under-tested or misrepresented product.
